DV
Dividend Vision

EXEL — Exelixis Inc.

Exelixis Inc. (EXEL)

Total return is 237.4% over the past 26.3 years, 484.3 points behind SPY at 721.7%. Its deepest 1-year drawdown was 16.5%.

EXEL is a single-stock equity holding in Exelixis Inc., a biotechnology company, rather than a diversified ETF fund. The holding generates no regular distributions and carries no stated expense ratio as it represents direct equity ownership. This structure appeals primarily to investors seeking exposure to a specific biotech company's growth potential rather than dividend income.

EXEL key facts

Asset type
Stock
Asset class
Equity
Inception date
04/11/2000
Distribution frequency
None
Last close
$51.24
Market cap
$12,696,334,336
Average volume
2342400.0
Beta
0.422
Payout ratio
0.0
P/E ratio
16.1132
Forward P/E
16.7224
EPS
$3.18